Differential Effects of Selective Cyclooxygenase-2 Inhibitors on Endothelial Function in Salt-Induced Hypertension

Authors:

Abstract
Background— In view of the ongoing controversy about potential differences in cardiovascular safety of selective cyclooxygenase (COX)-2 inhibitors (coxibs), we compared the effects of 2 different coxibs and a traditional NSAID on endothelial dysfunction, a well-established surrogate of cardiovascular disease, in salt-induced hypertension. Methods and Results— Salt-sensitive (DS) and salt-resistant (DR) Dahl rats were fed a high-sodium diet (4% NaCl) for 56 days. From days 35 to 56, diclofenac (6 mg · kg −1 · d −1 ; DS-diclofenac), rofecoxib (2 mg · kg −1 · d −1 ; DS-rofecoxib), celecoxib (25 mg · kg −1 · d −1 ; DS-celecoxib) or placebo (DS-placebo) was added to the chow. Blood pressure increased with sodium diet in the DS groups, which was more pronounced after diclofenac and rofecoxib treatment ( P P −10 -10 −5 mol/L) in aortic rings of untreated hypertensive rats ( P P N ω -nitro- l -arginine methyl ester (10 −4 mol/L) was blunted in DS rats ( P P Conclusions— These data show that celecoxib but not rofecoxib or diclofenac improves endothelial dysfunction and reduces oxidative stress, thus pointing to differential effects of coxibs in salt-induced hypertension.

This publication has 15 references indexed in Scilit: